Eye Allergy Treatment Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment, Indications, Distribution Channel, and Geography

Description

List of Tables

The eye allergy treatment market size is expected to grow from US$ 3.92 billion in 2024 to US$ 5.97 billion by 2031; it is projected to register a CAGR of 6.3% during 2025-2031. The increasing eye allergy prevalence, surging geriatric population, and prescription to over-the-counter transition are noteworthy factors contributing to the expansion of the eye allergy treatment market size. Additionally, the sustained-release ocular implants and drug-eluting contact lenses are projected to bring new eye allergy treatment market trends in the near future.

Biologics and immunomodulators are used for treating severe conditions such as vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC). These therapies not only target but also eliminate the main causes of chronic inflammation, such as T-cell response dysregulation and cytokine overproduction, thus providing steroid-sparing options that carry lower risks of glaucoma and cataracts in the long run. This trend is being facilitated by the precision medicine approach, as shown in clinical trials where refractory cases had remission rates of up to 80%, while traditional topical treatments had rates of 50-60% only. Immunomodulators, such as topical cyclosporine A (Restasis) and tacrolimus (Protopic ophthalmic), are the drugs that inhibit the activity of calcineurin, thereby preventing the activation of T-cells and bringing down the number of eosinophils involved in the inflammation. A network meta-analysis conducted in 2024 involving 28 randomized trials rated tacrolimus as the top drug for VKC.

Biologics, which are monoclonal antibodies that target single pathways, are becoming the treatment of choice for the medical side of allergies with ocular manifestations. Dupilumab (Dupixent), an IL-4/IL-13 inhibitor, has been shown to improve the ocular scores in patients with AKC by 75% in phase 3 clinical trials, and at the same time, it has been relieving itch and light sensitivity in adults with co-existing atopic dermatitis. Omalizumab (Xolair), an anti-IgE agent, has been able to cut emergency visits by 55% in the population of patients suffering from acute allergic conjunctivitis. The new drug lirentelimab, an anti-Siglec-8 antibody, is also on the horizon, having achieved 90% pledged eosinophil infiltration reduction in VKC phase 2 data, thus earning its place as a frontline biologic in the future. As a result of the increasing cases of allergic eye disease worldwide, the aforementioned innovations not only promise to improve quality of life but also to reduce the frequency of flare-ups and to make long-term management safer for the most vulnerable patients, and are expected to emerge as a significant trend in the eye allergy treatment market.

Distribution Channel-Based Insights

Based on distribution channel, the eye allergy treatment market is segmented into the hospital pharmacies, online pharmacy, and drug stores. The hospital pharmacies segment held the largest eye allergy treatment market share in 2024. In the healthcare facilities, these outlets play an important role where ophthalmologists and allergists diagnose and treat conditions such as allergic conjunctivitis, vernal keratoconjunctivitis, and giant papillary conjunctivitis with medicines. Medications like olopatadine hydrochloride (Pataday) and loteprednol etabonate (Lotemax) eye drops, for example, are often sold in these outlets, and they are not infrequently prescribed in-depth evaluations in hospital settings. There are several reasons leading to the development of this segment. The first one is that the rapidly increasing number of eye allergies, aggravated by environmental conditions, urbanization, and climate change, not only attracts more patients but also increases the demand for pharmaceutical services onsite since hospitals are becoming the patients' first choice for specialized care The growth of hospital pharmacies is a reflection of a combination of clinical reliability, policy support, and evolving patient needs, thus, they are recognized as a crucial channel for effective eye allergy management in a world that is increasingly becoming allergy-burdened, thereby fueling the eye allergy treatment market growth.

The World Health Organization and Asthma and Allergy Foundation of America are among the primary and secondary sources referred to while preparing the eye allergy treatment market report.

Product Code: TIPRE00007418

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
3.3 Assumptions and Limitations

4. Eye Allergy Treatment Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 List of Vendors in the Value Chain

5. Eye Allergy Treatment Market - Key Market Dynamics

5.1 Eye Allergy Treatment Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Eye Allergies Prevalence
- 5.2.2 Surging Geriatric Population
- 5.2.3 Prescription to Over-the-Counter Transition
5.3 Market Restraints
- 5.3.1 Stringent Regulatory Approvals
- 5.3.2 Side Effects Associated with Medications
- 5.3.3 Increasing Number of Product Recalls
5.4 Market Opportunities
- 5.4.1 Heightened Awareness and Treatments
- 5.4.2 Rising Strategic Initiatives by Companies
- 5.4.3 Emerging Market Penetration
5.5 Future Trends
- 5.5.1 Sustained-Release Ocular Implants and Drug-Eluting Contact Lenses
- 5.5.2 Preservative-Free, Multi-Action andldquo;Smartandrdquo; Eye Drops
- 5.5.3 Biologics and Immunomodulators for Severe Cases
5.6 Impact of Drivers and Restraints:

6. Eye Allergy Treatment Market - Global Market Analysis

6.1 Eye Allergy Treatment Market Revenue (US$ Million), 2021-2031
6.2 Eye Allergy Treatment Market Forecast Analysis

7. Eye Allergy Treatment Market Analysis - by Treatment

7.1 Oral Medication
- 7.1.1 Overview
- 7.1.2 Oral Medication: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Allergy Shots
- 7.2.1 Overview
- 7.2.2 Allergy Shots: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Eye Drops
- 7.3.1 Overview
- 7.3.2 Eye Drops: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)

8. Eye Allergy Treatment Market Analysis - by Indications

8.1 Seasonal and Perennial Allergic Conjunctivitis
- 8.1.1 Overview
- 8.1.2 Seasonal and Perennial Allergic Conjunctivitis: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Vernal Keratoconjunctivitis
- 8.2.1 Overview
- 8.2.2 Vernal Keratoconjunctivitis: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Atopic Keratoconjunctivitis
- 8.3.1 Overview
- 8.3.2 Atopic Keratoconjunctivitis: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Contact Allergic Conjunctivitis
- 8.4.1 Overview
- 8.4.2 Contact Allergic Conjunctivitis: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Giant Papillary Conjunctivitis
- 8.5.1 Overview
- 8.5.2 Giant Papillary Conjunctivitis: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)

9. Eye Allergy Treatment Market Analysis - by Distribution Channel

9.1 Hospital Pharmacies
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacies: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Online Pharmacy
- 9.2.1 Overview
- 9.2.2 Online Pharmacy: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Drug Stores
- 9.3.1 Overview
- 9.3.2 Drug Stores: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)

10. Eye Allergy Treatment Market - Geographical Analysis

10.1 North America
- 10.1.1 North America Eye Allergy Treatment Market Overview
- 10.1.2 North America: Eye Allergy Treatment Market - Revenue, 2021-2031 (US$ Million)
  - 10.1.2.1 North America: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Treatment
  - 10.1.2.2 North America: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Indications
  - 10.1.2.3 North America: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Distribution Channel
- 10.1.3 North America: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Country
  - 10.1.3.1 United States: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.1.1 United States: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.1.3.1.2 United States: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.1.3.1.3 United States: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.1.3.2 Canada: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.2.1 Canada: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.1.3.2.2 Canada: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.1.3.2.3 Canada: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.1.3.3 Mexico: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.3.1 Mexico: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.1.3.3.2 Mexico: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.1.3.3.3 Mexico: Eye Allergy Treatment Market Breakdown, by Distribution Channel
10.2 Europe
- 10.2.1 Europe Eye Allergy Treatment Market Overview
- 10.2.2 Europe: Eye Allergy Treatment Market - Revenue, 2021-2031 (US$ Million)
  - 10.2.2.1 Europe: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Treatment
  - 10.2.2.2 Europe: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Indications
  - 10.2.2.3 Europe: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Distribution Channel
- 10.2.3 Europe: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Country
  - 10.2.3.1 United Kingdom: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.1.1 United Kingdom: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.2.3.1.2 United Kingdom: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.2.3.1.3 United Kingdom: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.2.3.2 Germany: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.2.1 Germany: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.2.3.2.2 Germany: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.2.3.2.3 Germany: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.2.3.3 France: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.3.1 France: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.2.3.3.2 France: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.2.3.3.3 France: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.2.3.4 Spain: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.4.1 Spain: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.2.3.4.2 Spain: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.2.3.4.3 Spain: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.2.3.5 Italy: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.5.1 Italy: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.2.3.5.2 Italy: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.2.3.5.3 Italy: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.2.3.6 Rest of Europe: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.6.1 Rest of Europe: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.2.3.6.2 Rest of Europe: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.2.3.6.3 Rest of Europe: Eye Allergy Treatment Market Breakdown, by Distribution Channel
10.3 Asia Pacific
- 10.3.1 Asia Pacific Eye Allergy Treatment Market Overview
- 10.3.2 Asia Pacific: Eye Allergy Treatment Market - Revenue, 2021-2031 (US$ Million)
  - 10.3.2.1 Asia Pacific: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Treatment
  - 10.3.2.2 Asia Pacific: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Indications
  - 10.3.2.3 Asia Pacific: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Distribution Channel
- 10.3.3 Asia Pacific: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Country
  - 10.3.3.1 China: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.1.1 China: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.3.3.1.2 China: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.3.3.1.3 China: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.3.3.2 Japan: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.2.1 Japan: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.3.3.2.2 Japan: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.3.3.2.3 Japan: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.3.3.3 India: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.3.1 India: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.3.3.3.2 India: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.3.3.3.3 India: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.3.3.4 Australia: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.4.1 Australia: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.3.3.4.2 Australia: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.3.3.4.3 Australia: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.3.3.5 South Korea: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.5.1 South Korea: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.3.3.5.2 South Korea: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.3.3.5.3 South Korea: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.3.3.6 Rest of APAC: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.6.1 Rest of APAC: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.3.3.6.2 Rest of APAC: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.3.3.6.3 Rest of APAC: Eye Allergy Treatment Market Breakdown, by Distribution Channel
10.4 Middle East and Africa
- 10.4.1 Middle East and Africa Eye Allergy Treatment Market Overview
- 10.4.2 Middle East and Africa: Eye Allergy Treatment Market - Revenue, 2021-2031 (US$ Million)
  - 10.4.2.1 Middle East and Africa: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Treatment
  - 10.4.2.2 Middle East and Africa: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Indications
  - 10.4.2.3 Middle East and Africa: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Distribution Channel
- 10.4.3 Middle East and Africa: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Country
  - 10.4.3.1 Saudi Arabia: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.1.1 Saudi Arabia: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.4.3.1.2 Saudi Arabia: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.4.3.1.3 Saudi Arabia: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.4.3.2 South Africa: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.2.1 South Africa: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.4.3.2.2 South Africa: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.4.3.2.3 South Africa: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.4.3.3 United Arab Emirates: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.3.1 United Arab Emirates: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.4.3.3.2 United Arab Emirates: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.4.3.3.3 United Arab Emirates: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.4.3.4 Rest of Middle East and Africa: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.4.1 Rest of Middle East and Africa: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.4.3.4.2 Rest of Middle East and Africa: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.4.3.4.3 Rest of Middle East and Africa: Eye Allergy Treatment Market Breakdown, by Distribution Channel
10.5 South and Central America
- 10.5.1 South and Central America Eye Allergy Treatment Market Overview
- 10.5.2 South and Central America: Eye Allergy Treatment Market - Revenue, 2021-2031 (US$ Million)
  - 10.5.2.1 South and Central America: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Treatment
  - 10.5.2.2 South and Central America: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Indications
  - 10.5.2.3 South and Central America: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Distribution Channel
- 10.5.3 South and Central America: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Country
  - 10.5.3.1 Brazil: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.1.1 Brazil: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.5.3.1.2 Brazil: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.5.3.1.3 Brazil: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.5.3.2 Argentina: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.2.1 Argentina: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.5.3.2.2 Argentina: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.5.3.2.3 Argentina: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.5.3.3 Rest of South and Central America: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.3.1 Rest of South and Central America: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.5.3.3.2 Rest of South and Central America: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.5.3.3.3 Rest of South and Central America: Eye Allergy Treatment Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis by Key Players
11.2 Company Market Share Analysis, 2024

12. Industry Landscape

12.1 Overview
12.2 Market Initiative

13. Company Profiles

13.1 Alcon AG
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Bausch + Lomb Corporation
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 AdvaCare Pharma USA LLC
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 AbbVie Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Sun Pharmaceutical Industries Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Grevis Pharmaceuticals Pvt Ltd.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Santen Pharmaceutical Co., Ltd.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Bayer AG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 ZEXUS PHARMA
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Lupin Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 List of Abbreviations